株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

世界の骨・関節の再生医療市場:産業分析・規模・シェア・成長率・動向・予測

Regenerative Medicine Market (Bone and Joint) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

発行 Transparency Market Research 商品コード 309698
出版日 ページ情報 英文 85 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.71円で換算しております。
Back to Top
世界の骨・関節の再生医療市場:産業分析・規模・シェア・成長率・動向・予測 Regenerative Medicine Market (Bone and Joint) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
出版日: 2014年07月01日 ページ情報: 英文 85 Pages
概要

米国の国立衛生研究所(NIH)によれば、再生医療とは損傷や先天的欠損、病気、年齢などにより機能を喪失した細胞や組織を修復あるいは置換するための機能的組織を創出するプロセスであるとされており、これには幹細胞治療や組織工学、バイオマテリアルなども含まれています。再生医療には、心血管系、神経系、整形外科関連、筋骨格系の疾患や障害など、さまざまな応用分野があります。

当レポートでは、世界の骨・関節の再生医療市場について調査し、再生医療の各種区分と概要、市場成長の推進因子・阻害因子および市場機会の分析、技術区分・用途・地域別の市場成長予測、新規参入事業者および既存事業者への提言、主要事業者のプロファイル、製品ポートフォリオ、事業戦略などをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 概要
  • 市場成長推進因子
  • 市場成長阻害因子
  • 市場機会
  • ポーターのファイブフォース分析
  • 競合環境
  • 市場の魅力度分析

第4章 骨・関節の再生医療市場:技術別

  • イントロダクション
  • 幹細胞治療
  • バイオマテリアル
  • 組織工学

第5章 骨・関節の再生医療市場:用途別

  • 概要
  • 代用骨移植片
  • 骨関節疾患
  • 同種異系骨
  • 自家骨
  • その他

第6章 骨・関節の再生医療市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第7章 提言

  • 成長のための市場戦略
    • 革新的製品のための厳密なR&Dイニシアチブ
    • 新興国への投資
  • 障壁と将来の予測
    • 幹細胞治療に関する倫理的課題が市場成長の妨げに

第8章 企業プロファイル

  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • Baxter International, Inc.
  • CONMED Corporation
  • DePuy Synthes, Inc.
  • Medtronic, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Holdings, Inc.
    • 事業概要
    • 財務概要
    • 製品ポートフォリオ
    • 事業戦略
    • 最近の取り組み

図表

目次

Title: Regenerative Medicine Market (Bone and Joint) (By Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; By Applications - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019.

U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology, orthopedic and musculoskeletal diseases and disorders. This research report explains various advancements occurring in this market and analyzes the global regenerative medicine (bone and joint) market by technology and application as well as geographic region. The regenerative medicine (bone and joint) market report comprises an elaborate executive summary, which includes market snapshot that provides overall information of various segments and sub-segments that are contained in the report. Comparative analysis has also been included in the executive summary that resembles the percentage market share of each region (North America, Europe, Asia-Pacific, RoW) in 2012 and 2019 respectively.

The global market for regenerative medicine is segmented based on technology into stem cell therapy, biomaterials and tissue engineering. The market for these technologies has been extensively analyzed based on consistency, effectiveness and sales revenue of the product developed by the technologies. The market size and forecast in terms of USD million for each technology type has been provided for the period 2011 to 2019. The report on the regenerative medicine (bone and joint) market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.

In addition, the global market for regenerative medicine (bone and joint) is segmented based on application into bone graft substitute, osteoarticular diseases, allogeneic bones, autogenic bones and others. The market for these applications of regenerative medicine (bone and joint) has been extensively analyzed based on surgeries performed, sales revenue of the required devices and their geographic distribution. The market size and forecast in terms of USD million for each application has been provided for the period 2011 to 2019. The report on the regenerative medicine (bone and joint) market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.

Market size estimations involved in-depth study of demand of regenerative medicine bone and joint products in hospitals, clinics and research organizations and average price range of each segment. Additionally, disease prevalence, geographic presence and historical year-on-year growth has been taken into consideration for calculating the market size. The market size estimated for each category is based on secondary data obtained for all the above factors cumulatively. The data obtained from secondary research was analyzed extensively and has been validated with the help of industry experts in order to arrive at the most accurate market size estimations.

Geographically, the regenerative medicine (bone and joint) market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2011 to 2019 along with CAGR (%) for the forecast period 2013 to 2019. The research study also incorporates the competitive scenario of major players in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global regenerative medicine (bone and joint) market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter's five forces analysis, and key players' market share analysis in 2012 in the regenerative medicine market for bone and joint applications.

A list of recommendations has been provided for new entrants to help establish a strong presence and for existing market players to increase market share. The report also profiles major players in the regenerative medicine (bone and joint) market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major market players profiled in this report includes Anika Therapeutics, Inc., Arthrex, Inc., Baxter International, Inc., CONMED Corporation, DePuy Synthes, Inc., Medtronic, Inc., Smith & Nephew PLC, Stryker Corporation and Zimmer Holdings, Inc.

The global regenerative medicine (bone and joint) market is segmented as follows:

Regenerative Medicine (Bone and Joint) Market, by Technology

  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering

Regenerative Medicine (Bone and Joint) Market, by Application

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Allogeneic Bones
  • Autogenic Bones
  • Others

Regenerative Medicine (Bone and Joint) Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Assumptions
  • 1.4. List of Abbreviations

Chapter 2 - Executive Summary

  • 2.1. Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019)
  • 2.2. Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million)
  • 2.3. Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 and 2019 (Value %)

Chapter 3 - Market Overview

  • 3.1. Overview
  • 3.2. Market Drivers
    • 3.2.1. Technological innovations in biomaterials, stem cell therapy and tissue engineering are fueling the development of regenerative medicine products
    • 3.2.2. Growing prevalence of bone and joint disorders demand the growth of regenerative medicine products
    • 3.2.3. Growing number of orthopedic surgeries fuels the growth of the global regenerative medicine (bone and joint) market
  • 3.3. Restraints
    • 3.3.1. Regulatory constraints pose a threat to the development of regenerative medicine (bone and joint) market
    • 3.3.2. Ethical issues and post implantation infections are hindering overall market growth
  • 3.4. Opportunities
    • 3.4.1. Capitalization on the potential presented by emerging markets in Asia Pacific
  • 3.5. Porter's Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. Threat of new entrants
    • 3.5.4. Threat of substitutes
    • 3.5.5. Competitive rivalry
  • 3.6. Competitive Landscape
    • 3.6.1. Market Share Analysis by Key Players, 2012 (Value %)
  • 3.7. Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography

Chapter 4 - Regenerative Medicine (Bone and Joint) Market, by Technology

  • 4.1. Introduction
    • 4.1.1. Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • 4.2. Stem Cell Therapy
    • 4.2.1. Global Stem Cell Therapy Market Revenue, 2011 - 2019 (USD Million)
  • 4.3. Biomaterials
    • 4.3.1. Global Biomaterials Market Revenue, 2011 - 2019 (USD Million)
  • 4.4. Tissue Engineering
    • 4.4.1. Global Tissue Engineering Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 - Regenerative Medicine (Bone and Joint) Market, by Applications

  • 5.1. Overview
    • 5.1.1. Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • 5.2. Bone Graft Substitutes
    • 5.2.1. Global Bone Graft Substitute Application Market Revenue, 2011 - 2019 (USD Million)
  • 5.3. Osteoarticular Diseases
    • 5.3.1. Global Osteoarticular Diseases Application Market Revenue, 2011 - 2019 (USD Million)
  • 5.4. Allogeneic Bones
    • 5.4.1. Global Allogenic Bones Application Market Revenue, 2011 - 2019 (USD Million)
  • 5.5. Autogenic Bones
    • 5.5.1. Global Autogenic Bone Application Market Revenue, 2011 - 2019 (USD Million)
  • 5.6. Others
    • 5.6.1. Global Others Application Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 - Regenerative Medicine (Bone and Joint) Market, by Geography

  • 6.1. Overview
    • 6.1.1. Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 - 2019 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • 6.4. Asia-Pacific
    • 6.4.1. Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • 6.5. Rest of the World (RoW)
    • 6.5.1. RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 - Recommendations

  • 7.1. Market Strategy for Success
    • 7.1.1. Rigorous research and development initiatives for innovative products
    • 7.1.2. Investing in emerging economies
  • 7.2. Barriers and Future Assumptions
    • 7.2.1. Ethical issues pertaining to stem cell therapy hampering market growth

Chapter 8 - Company Profiles

  • 8.1. Anika Therapeutics, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Financial Overview
    • 8.1.3. Product Portfolio
    • 8.1.4. Business Strategies
    • 8.1.5. Recent Developments
  • 8.2. Arthrex, Inc.
    • 8.2.1. Company Overview
    • 8.2.2. Financial Overview
    • 8.2.3. Product Portfolio
    • 8.2.4. Business Strategies
    • 8.2.5. Recent Developments
  • 8.3. Baxter International, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Financial Overview
    • 8.3.3. Product Portfolio
    • 8.3.4. Business Strategies
    • 8.3.5. Recent Developments
  • 8.4. CONMED Corporation
    • 8.4.1. Company Overview
    • 8.4.2. Financial Overview
    • 8.4.3. Product Portfolio
    • 8.4.4. Business Strategies
    • 8.4.5. Recent Developments
  • 8.5. DePuy Synthes, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Financial Overview
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Strategies
    • 8.5.5. Recent Developments
  • 8.6. Medtronic, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Financial Overview
    • 8.6.3. Product Portfolio
    • 8.6.4. Business Strategies
    • 8.6.5. Recent Developments
  • 8.7. Smith & Nephew plc
    • 8.7.1. Company Overview
    • 8.7.2. Financial Overview
    • 8.7.3. Product Portfolio
    • 8.7.4. Business Strategies
    • 8.7.5. Recent Developments
  • 8.8. Stryker Corporation
    • 8.8.1. Company Overview
    • 8.8.2. Financial Overview
    • 8.8.3. Product Portfolio
    • 8.8.4. Business Strategies
    • 8.8.5. Recent Developments
  • 8.9. Zimmer Holdings, Inc.
    • 8.9.1. Business Overview
    • 8.9.2. Financial Overview
    • 8.9.3. Product Portfolio
    • 8.9.4. Business Strategies
    • 8.9.5. Recent Developments

List of Figures

  • FIG. 1: Regenerative Medicine (Bone and Joint): Market Segmentation
  • FIG. 2: Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million)
  • FIG. 3: Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 & 2019 (Value %)
  • FIG. 4: Porter's Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market
  • FIG. 5: Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %)
  • FIG. 6: Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 Value (%)
  • FIG. 7: Global Stem Cell Therapy Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 8: Global Biomaterials Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 9: Global Tissue Engineering Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 10: Global Bone Graft Substitute Application Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 11: Global Osteoarticular Diseases Application Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 12: Global Allogeneic Bones Application Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 13: Global Autogenic Bone Application Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 14: Global Others Application Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 15: North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 16: Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 17: Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 18: RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 - 2019 (USD Million)
  • FIG. 19: Anika Therapeutics, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 20: Baxter International, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 21: Conmed Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 22: Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 - 2013 (USD Million)
  • FIG. 23: Medtronic, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 24: Smith & Nephew PLC: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 25: Stryker Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 26: Zimmer Holdings. Inc,: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1: List of Abbreviations
  • TABLE 2: Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019)
  • TABLE 3: Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 - 2019 (USD Million)
  • TABLE 4: Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 - 2019 (USD Million)
  • TABLE 5: Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 - 2019 (USD Million)
Back to Top